Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% ...

Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion.

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...

Investing.com -- Lundbeck (CSE: HLUNb) on Wednesday raised its full-year revenue and earnings guidance after reporting a 16% increase in first-quarter revenue at constant exchange rates to DKK 6.24 ...

The operating environment has been challenging for the company due to decreasing sales worldwide and the effects of U.S.

Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.

The Wall Street veteran's technical analysis of natural gas helped members capture gains on UNG calls. His recent alert ...

The company posted adjusted earnings per share of ... Based on the robust Q1 results, Exelixis raised its full-year 2025 revenue guidance to $2.25-$2.35 billion, up from its previous forecast ...

Dow Jones Top Financial Services Headlines at 7 AM ET: Bags of Cash From Drug Cartels Flood Teller Windows at U.S. Banks | Allianz ... Bags of Cash From Drug Cartels Flood Teller Windows at U.S. Banks ...